{"id":2866,"date":"2023-09-28T12:27:03","date_gmt":"2023-09-28T12:27:03","guid":{"rendered":"https:\/\/www.palladiumcapital.com\/?p=2866"},"modified":"2023-09-28T17:41:29","modified_gmt":"2023-09-28T17:41:29","slug":"palladium-capital-group-sole-placement-agent-for-26000000-debt-financing-for-glytec","status":"publish","type":"post","link":"https:\/\/www.palladiumcapital.com\/palladium-capital-group-sole-placement-agent-for-26000000-debt-financing-for-glytec\/","title":{"rendered":"Palladium Capital Exclusive Placement Agent for $26,000,000 Debt Financing for Glytec"},"content":{"rendered":"<p><a href=\"https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2023\/08\/2023-08-Glytec-Tombstone-1.jpg\"><img decoding=\"async\" loading=\"lazy\" class=\"size-medium wp-image-2880 alignright\" src=\"https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2023\/08\/2023-08-Glytec-Tombstone-1-263x300.jpg\" alt=\"\" width=\"263\" height=\"300\" srcset=\"https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2023\/08\/2023-08-Glytec-Tombstone-1-263x300.jpg 263w, https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2023\/08\/2023-08-Glytec-Tombstone-1-150x171.jpg 150w, https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2023\/08\/2023-08-Glytec-Tombstone-1.jpg 570w\" sizes=\"(max-width: 263px) 100vw, 263px\" \/><\/a><\/p>\n<p>NEW YORK, NY \u2013 On September 28, 2023, Palladium Capital Group, LLC announced that it facilitated the private placement of a $26 million senior secured loan for Glytec, LLC and its parent company, Aseko, Inc. in August 2023.<\/p>\n<p><strong>About Glytec<\/strong><\/p>\n<p>Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment \u2013 including those with and without a diagnosis of diabetes. For more information, follow Glytec on Twitter\u00a0(<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fglytec&amp;esheet=52483994&amp;newsitemid=20210831005245&amp;lan=en-US&amp;anchor=%40Glytec&amp;index=9&amp;md5=f53b569113d0b5bd42958721746f67bf\" target=\"_blank\" rel=\"noopener\">@Glytec<\/a>)\u00a0and<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fglytec-llc&amp;esheet=52483994&amp;newsitemid=20210831005245&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=10&amp;md5=7d2d10607f8fe1761db9359b387928b4\" target=\"_blank\" rel=\"noopener\">\u00a0LinkedIn<\/a>,\u00a0or visit<a href=\"https:\/\/www.glytecsystems.com\/\">\u00a0www.GlytecSystems.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, NY \u2013 On September 28, 2023, Palladium Capital Group, LLC announced that it facilitated the private placement of a $26 million senior secured loan for Glytec, LLC and its parent company, Aseko, Inc. in August 2023. About Glytec Glytec is the insulin management software company for healthcare providers focused on improving the quality [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"_links":{"self":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts\/2866"}],"collection":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/comments?post=2866"}],"version-history":[{"count":6,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts\/2866\/revisions"}],"predecessor-version":[{"id":2885,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts\/2866\/revisions\/2885"}],"wp:attachment":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/media?parent=2866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/categories?post=2866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/tags?post=2866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}